- Home
- EML vs MYO Comparison
EML vs MYO Comparison
Compare EML & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- MYO
- Stock Information
- Founded
- EML 1858
- MYO 2004
- Country
- EML United States
- MYO United States
- Employees
- EML N/A
- MYO N/A
- Industry
- EML Industrial Machinery/Components
- MYO Industrial Specialties
- Sector
- EML Consumer Discretionary
- MYO Health Care
- Exchange
- EML Nasdaq
- MYO Nasdaq
- Market Cap
- EML 144.5M
- MYO 153.0M
- IPO Year
- EML N/A
- MYO 2017
- Fundamental
- Price
- EML $23.50
- MYO $1.97
- Analyst Decision
- EML
- MYO Strong Buy
- Analyst Count
- EML 0
- MYO 3
- Target Price
- EML N/A
- MYO $9.67
- AVG Volume (30 Days)
- EML 8.4K
- MYO 458.1K
- Earning Date
- EML 08-05-2025
- MYO 08-08-2025
- Dividend Yield
- EML 1.86%
- MYO N/A
- EPS Growth
- EML N/A
- MYO N/A
- EPS
- EML N/A
- MYO N/A
- Revenue
- EML $271,440,503.00
- MYO $38,628,624.00
- Revenue This Year
- EML $1.56
- MYO $55.29
- Revenue Next Year
- EML $7.00
- MYO $27.18
- P/E Ratio
- EML $11.20
- MYO N/A
- Revenue Growth
- EML 8.15
- MYO 97.60
- 52 Week Low
- EML $19.06
- MYO $1.85
- 52 Week High
- EML $35.03
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- EML 51.73
- MYO 33.51
- Support Level
- EML $23.21
- MYO $1.85
- Resistance Level
- EML $23.70
- MYO $2.20
- Average True Range (ATR)
- EML 0.49
- MYO 0.14
- MACD
- EML -0.03
- MYO 0.04
- Stochastic Oscillator
- EML 47.03
- MYO 23.36
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).